Successful treatment of facial systemic lupus erythematosus lesions with Dr Michaels® (Soratinex®) product family. A case report


Article ID: 6677
Vol 30, Issue 2S3, 2016
DOI: https://doi.org/10.54517/jbrha6677
Received: 9 July 2016; Accepted: 9 July 2016; Available online: 9 July 2016; Issue release: 9 July 2016

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease in which the bodys immune system mistakenly attacks healthy tissue. It can affect the skin, joints, kidneys, brain and other organs. We report the case of a 7-year-old female patient with facial lesions of SLE since the age of 5. There was no significant family history and patient had been a healthy child from birth. The child presented with a malar rash, also known as a butterfly rash, with distribution over the cheeks but sparing the nasal bridge. This case represents the efficacy of the Dr. Michaels® (Soratinex®) product family in the successful resolution of facial lesions of SLE.


Keywords

systemic lupus erythematosus;facial lesions;skin rash;butterfly erythema;malar rash


References

Supporting Agencies



Copyright (c) 2016




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).